Global Central Lab Services for Cardiology Clinical Trials
Navigating the scientific, operational, and regulatory complexity of modern cardiovascular drug development.
MLM Medical Labs provides global central and specialty laboratory support for cardiovascular clinical trials. As cardiovascular drug development becomes increasingly biomarker-driven and mechanistically focused, MLM provides sponsors with both the scientific partnership and operational infrastructure needed to support cardiovascular programs from translational biomarker strategy through global clinical trials.
Our cardiology capabilities support a wide range of therapeutic programs, including:
Anticoagulants (FXa/FXI) and reversal/antidote
Antiplatelet therapies and reversal/antidote
Heart failure
Metabolic/cardiovascular disease
Inflammation-driven cardiovascular conditions
Emerging translational biomarker strategies
Why Sponsors Partner with MLM: Hands-On Scientific Collaboration
MLM’s differentiator is not simply performing assays – it is providing sponsors with direct access to the scientific experts supporting their study.
Our translational and operational teams work closely with sponsors throughout the lifecycle of the trial to proactively address scientific and operational challenges before they become delays. This level of scientific accessibility and responsiveness is especially valuable in complex cardiovascular programs where assay performance directly impacts dose selection, safety interpretation, and clinical decision-making.
This collaborative model helps:
Accelerate study decision-making
Resolve assay and sample issues quickly
Eliminate preanalytical variables
Streamline communication between teams
Support rapid adaptation when protocols evolve
Keep complex cardiovascular studies moving forward efficiently
Our teams collaborate directly with sponsors on:
Assay selection and optimization
Pharmacodynamic strategy
Trigger and methodology evaluation for coagulation studies
Biomarker feasibility and implementation
Custom assay workflows
Sample stability and preanalytics
Translational & Cardiovascular Biomarker Expertise
MLM supports cardiovascular biomarker strategies ranging from routine cardiac safety markers to advanced translational assays. Our scientific teams work directly with sponsors to align assay strategy with study objectives, pharmacodynamic endpoints, and mechanism of action.
Capabilities include support for:
Cardiac Safety & Function: High-sensitivity Troponin I/T, NT-proBNP, NT-proANP, CK-MB, and Myoglobin
Hemodynamic Markers: CT-proAVP (Copeptin), Renin activity, and Aldosterone
Hemostasis & Coagulation: D-Dimer, Anti-Xa Activity, Platelet Function Testing, Thrombin Generation Assays (TGA), and Coagulation & Hemostasis Biomarkers
Advanced Analysis: Inflammatory and vascular biomarkers, Multiplex cytokine analysis, and Exploratory biomarker programs
Thrombin Generation & Coagulation Leadership
MLM has significant experience supporting anticoagulant development programs, including thrombin generation studies for Factor Xa and Factor XI inhibitor programs. We work with sponsors to help ensure assay sensitivity and pharmacodynamic interpretation are aligned to compound-specific biology and study goals.
Our capabilities include:
Multiple thrombin generation assay configurations
Trigger optimization strategies
Coagulation biomarker analysis
Platelet function testing
PK/PD assay support
Global sample handling and preanalytics management
Integrated Central & Specialty Lab Services
MLM combines routine central laboratory testing with advanced specialty and translational capabilities through a harmonized global laboratory network. This integrated approach simplifies study management while maintaining scientific depth and operational flexibility.
Services include:
Clinical chemistry and Hematology
Coagulation testing and Immunology
Flow cytometry and Multiplex testing
Biomarker sample management and Long-term biostorage
Global Trial Support
With wholly owned laboratory operations in Germany, the United States, and South Africa (Cytespace Africa Laboratories), MLM supports global cardiology studies with harmonized testing, regional logistics coordination, and responsive project management.
Our infrastructure includes:
Customized kit building
Global sample logistics
Real-time tracking and chain-of-custody
Temperature-controlled shipping solutions
Secure long-term sample storage
Quality & Regulatory Alignment
MLM operates under globally recognized quality standards, supporting cardiovascular clinical trials conducted under FDA, EMA, and international regulatory frameworks, with a strong focus on data integrity, harmonization, and operational reliability.
Standards include:
CAP Accreditation
CLIA Compliance
ISO 15189 Standards
Ready to support the next generation of cardiovascular therapies?
Partner with MLM Medical Labs for your upcoming cardiology clinical trial.